Title:
グリシン捕捉性アンタゴニストを用いる拒絶性および認知性精神分裂病症候群の処置
Document Type and Number:
Japanese Patent JP5363152
Kind Code:
B2
Abstract:
The amino acid glycine in an administered amount of above 0.4 g/Kg/day is used for treating symptoms of psychosis and of schizophrenia.
Inventors:
Daniel C. JAVITT
Application Number:
JP2009066534A
Publication Date:
December 11, 2013
Filing Date:
March 18, 2009
Export Citation:
Assignee:
Daniel C. JAVITT
International Classes:
A61K31/19; A61K45/00; A61K31/00; A61K31/16; A61K31/195; A61K31/198; A61K31/22; A61K31/223; A61K45/06; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P39/02; A61P43/00
Domestic Patent References:
| JP2083317A |
Foreign References:
| WO1993010228A1 |
Other References:
Eugene Toth, et al.,Research Communications in Psychology, Psychiatry and Behavior,米国,1986年,11(1),pp.1-9
Daniel C. Javitt, et al.,Am. J. Psychiatry,米国,1991年,148,pp.1301-1308
TOSHITAKA NABESHIMA, et al.,European Journal of Pharmacology,1983年,91,pp.455-462
L. J. Bristow, et al.,Br. J. Pharmacol.,英国,1993年,108,pp.1156-1163
RAUL ALLAN KIIVET, et al.,Br. J. Clin. Pharmacol.,英国,1995年,40,pp.467-476
松野敏行ら,九州神経精神医学,日本,1994年,40(1),pp.117-128
Francisco Zafra, et al.,The Journal of Neuroscience,米国,1995年,15(5),pp.3952-3969
Daniel C. Javitt, et al.,Am. J. Psychiatry,米国,1991年,148,pp.1301-1308
TOSHITAKA NABESHIMA, et al.,European Journal of Pharmacology,1983年,91,pp.455-462
L. J. Bristow, et al.,Br. J. Pharmacol.,英国,1993年,108,pp.1156-1163
RAUL ALLAN KIIVET, et al.,Br. J. Clin. Pharmacol.,英国,1995年,40,pp.467-476
松野敏行ら,九州神経精神医学,日本,1994年,40(1),pp.117-128
Francisco Zafra, et al.,The Journal of Neuroscience,米国,1995年,15(5),pp.3952-3969
Attorney, Agent or Firm:
Seiji Ohno
Reiko Tanaka
Yuko Matsuniya
Ken Kitano
Natsuki Ito
Reiko Tanaka
Yuko Matsuniya
Ken Kitano
Natsuki Ito